首页> 外文OA文献 >Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

【2h】

Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

机译：评估血浆微稻草作为胰腺癌中的诊断和预后生物标志物：miR-196a和miR-210分别是负性和正预后标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Qi Yu; Changqing Xu; Wei Yuan; Chengfeng Wang; Ping Zhao; Lianzhen Chen; Jie Ma;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers [J] . Dan Calatayud, Christian Dehlendorff, Mogens K. Boisen, Biomarker Research . 2017,第1期

机译：组织MicroRNA谱作为可切除的胰腺导管腺癌和壶腹周围癌患者的诊断和预后生物标志物
2. A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma [J] . Yang Yu, Xiao Feng, Shundong Cang Cancer Management and Research . 2018,第4期

机译：两种microRNA标记物作为胰腺腺癌的诊断和预后标志物
3. Plasma microRNA profiles: identification of miR-744 as a novel diagnostic and prognostic biomarker in pancreatic cancer [J] . Mahito Miyamae, Shuhei Komatsu, Daisuke Ichikawa, British Journal of Cancer . 2015,第10期

机译：血浆microRNA谱：鉴定miR-744作为胰腺癌的新型诊断和预后生物标志物
4. Promising Biomarkers: MicroRNAs at Diagnosis, Therapy and Prognostic Evaluation of Breast Cancer [C] . Dalin Lu, Nan Wang, Xinghua Liao, International conference on applied biotechnology . 2014

机译：有前途的生物标志物：MicroRNA在乳腺癌的诊断，治疗和预后评估中的作用
5. The CA19-9 Antigen and sTRA Glycans Define Independent Pancreatic Ductal Adenocarcinoma Subpopulations Improving Diagnostic Accuracy and Approach to Prognostic Classification [D] . Barnett, Daniel Mark. 2020

机译：Ca19-9抗原和stra聚糖定义独立的胰腺导管腺癌群，提高了预后分类的诊断准确性和方法
6. Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively [O] . Qi Yu, Changqing Xu, Wei Yuan, 2006

机译：血浆MicroRNA作为胰腺癌诊断和预后生物标志物的评估：miR-196a和miR-210可能分别是阴性和阳性预后标志物
7. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers [O] . 2017

机译：组织MicroRNA谱作为可切除胰管腺癌和壶腹周围癌患者的诊断和预后生物标志物

Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively

著录项

引文网络

相似文献

相关主题

期刊订阅